1. ALLA AKTIER
  2. NYHETER
  3. LUMITO

Lumito

Nyheter Lumito Nyheter alla bolag

Lumito signs an agreement with Uniogen Oy

MARKN.

Lumito AB and the Finnish company Uniogen Oy have signed a cooperation agreement for the production of Lumito’s immunohistochemical reagent kit, SCIZYS Erbium Kit. The reagent kit is part of Lumito’s product offering and is based on upconverted nanoparticles.

Since June 2022, Lumito has had a Letter of Intent in place with Uniogen Oy (formerly Kaivogen Oy).

- Lumito's product is an excellent example of the superior sensitivity of Upcon® technology. The cooperation brings us a completely new application platform for Upcon particles, comments Ilari Antila, Uniogen’s CEO.

- The fact that we now have a production agreement in place with Uniogen Oy is important and ensures the production of our reagent kits before the start of sales, comments Mattias Lundin, Lumito’s CEO.

The 5-year production agreement means that Uniogen is the manufacturer of Lumito’s SCIZYS Erbium Kit.

For further information, please contact:

Mattias Lundin, CEO Lumito
E-mail: ml@lumito.se
Ph: +46 76 868 45 09 

Lumito

Lumito specialises in medical technology for digital pathology. Through its proprietary and patented technology, Lumito aims to provide healthcare providers with a powerful tool to meet the demands for fast and safe tissue diagnostics in personalised healthcare. The technology enables higher-contrast images without irrelevant background information, making it easier for pathologists to find cancer indications. The technology, based on Up Converting NanoParticles (UCNP), has the potential to significantly improve the diagnosis of tissue samples through higher quality analyses and shortened analysis times. The method has several potential applications, but Lumito has focused primarily on digital pathology and first on a release of SCIZYS by Lumito for use in research laboratories. The company is a spin-off of a research group at the Department of Atomic Physics and Laser Centre. www.lumito.se/en

The share is traded on NGM Nordic SME under the name LUMITO, and Mentor is Mangold Fondkommission.

Uniogen Oy
Uniogen is a global pioneer in diagnostics solutions and instrumentation for life sciences. The company is specialised in the diagnostics of infectious and cancer diseases, and it develops diagnostic tests, point-of-care testing systems and laboratory instruments. A Finnish company, Uniogen currently employs over 100 experts.

Attachments
Lumito signs an agreement with Uniogen Oy

Datum 2023-09-20, kl 09:00
Källa MFN
Bifogade filer
Lumito signs an agreement with Uniogen Oy
Affiliate
Kopiera toppinvesterare! Med eToros innovativa CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för att använda CopyTrader-funktionen.
Copy Trading innebär inte investeringsråd. Värdet på dina investeringar kan gå upp eller ned. Ditt kapital löper risk.